Product Name
EYA1, Polyclonal Antibody
Popular Item
Full Product Name
Anti-EYA1 Antibody
Product Synonym Names
EYA1; Eyes absent homolog 1; EYA4; Eyes absent homolog 4
Product Gene Name
anti-EYA1 antibody
[Similar Products]
Product Synonym Gene Name
EYA4[Similar Products]
Antibody/Peptide Pairs
EYA1 peptide (MBS8200948) is used for blocking the activity of EYA1 antibody (MBS8234246)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for Q99502
Species Reactivity
Human, Mouse, Rat, Monkey, Zebrafish
Specificity
Recognizes endogenous levels of EYA1 protein.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the center region of human EYA1. The exact sequence is proprietary.
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C for one year. Avoid freeze/thaw cycles.
Other Notes
Small volumes of anti-EYA1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-EYA1 antibody
Rabbit polyclonal antibody to EYA1
Applications Tested/Suitable for anti-EYA1 antibody
Western Blot (WB)
Application Notes for anti-EYA1 antibody
WB (1/500 - 1/1000)
Western Blot (WB) of anti-EYA1 antibody
Western blot analysis of EYA1 expression in A549 (A), H9C2 (B) whole cell lysates.

NCBI/Uniprot data below describe general gene information for EYA1. It may not necessarily be applicable to this product.
NCBI Accession #
NP_000494.2
[Other Products]
NCBI GenBank Nucleotide #
NM_000503.5
[Other Products]
UniProt Primary Accession #
Q99502
[Other Products]
UniProt Secondary Accession #
Q0P516; Q8WX80; A6NHQ0; G5E9R4[Other Products]
UniProt Related Accession #
Q99502[Other Products]
NCBI Official Full Name
eyes absent homolog 1 isoform 1
NCBI Official Synonym Full Names
EYA transcriptional coactivator and phosphatase 1
NCBI Official Symbol
EYA1 [Similar Products]
NCBI Official Synonym Symbols
BOP; BOR; BOS1; OFC1
[Similar Products]
NCBI Protein Information
eyes absent homolog 1
UniProt Protein Name
Eyes absent homolog 1
Protein Family
Eyes absent
UniProt Gene Name
EYA1 [Similar Products]
UniProt Entry Name
EYA1_HUMAN
NCBI Summary for EYA1
This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may play a role in the developing kidney, branchial arches, eye, and ear. Mutations of this gene have been associated with branchiootorenal dysplasia syndrome, branchiootic syndrome, and sporadic cases of congenital cataracts and ocular anterior segment anomalies. A similar protein in mice can act as a transcriptional activator. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Dec 2013]
UniProt Comments for EYA1
EYA1: Tyrosine phosphatase that specifically dephosphorylates 'Tyr-142' of histone H2AX (H2AXY142ph). 'Tyr-142' phosphorylation of histone H2AX plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress. Promotes efficient DNA repair by dephosphorylating H2AX, promoting the recruitment of DNA repair complexes containing MDC1. Its function as histone phosphatase probably explains its role in transcription regulation during organogenesis. Seems to coactivate SIX2, SIX4 and SIX5. May be required for normal development of branchial arches, ear and kidney. Defects in EYA1 are the cause of branchiootorenal syndrome type 1 (BOR1); also known as Melnick-Fraser syndrome. BOR is an autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to mondini type cochlear defect and stapes fixation. Penetrance of BOR syndrome is high, although expressivity can be extremely variable. Defects in EYA1 are the cause of otofaciocervical syndrome (OFCS). The syndrome is characterized by trophic alterations of the facies and shoulder girdle in addition to the malformations seen in BOR. Defects in EYA1 are the cause of branchiootic syndrome type 1 (BOS1); also known as BO syndrome type 1 or branchiootic dysplasia. Individuals with BOS1 are affected by the same branchial and otic anomalies as those seen in individuals with BOR1, but lack renal anomalies. Defects in EYA1 are the cause of anterior segment anomalies with or without cataract (ASA). A disease characterized by various types of developmental eye anomalies, in the absence of other abnormalities. The phenotypic spectrum of anterior segment anomalies include central corneal opacity, Peters anomaly, and bilateral persistence of the pupillary membrane. Some patients have cataract. Belongs to the HAD-like hydrolase superfamily. EYA family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Motility/polarity/chemotaxis; DNA repair, damage; Apoptosis; Protein phosphatase, tyrosine (non-receptor); Cell development/differentiation; EC 3.1.3.16; EC 3.1.3.48
Chromosomal Location of Human Ortholog: 8q13.3
Cellular Component: cytoplasm; nucleus
Molecular Function: protein binding; RNA binding; metal ion binding; protein tyrosine phosphatase activity
Biological Process: histone dephosphorylation; striated muscle development; anatomical structure morphogenesis; positive regulation of DNA repair; pharyngeal system development; transcription, DNA-dependent; regulation of neuron differentiation; outer ear morphogenesis; semicircular canal morphogenesis; establishment and/or maintenance of apical/basal cell polarity; middle ear morphogenesis; pattern specification process; embryonic skeletal morphogenesis; protein sumoylation; sensory perception of sound; establishment of mitotic spindle orientation; ureteric bud branching; double-strand break repair; neuron fate specification; positive regulation of transcription from RNA polymerase II promoter; response to ionizing radiation; metanephros development; positive regulation of Notch signaling pathway; positive regulation of epithelial cell proliferation
Disease: Branchiootic Syndrome 1; Otofaciocervical Syndrome 1; Branchiootorenal Syndrome 1
Research Articles on EYA1
1. we proved that the branchiooto (BO) syndrome in these cases was caused by germinal mosaicism of the EYA1 gene in either the mother or father.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.